In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil

ABSTRACT The in vitro susceptibility of 105 clinical and environmental strains of Aspergillus fumigatus and Aspergillus flavus to antifungal drugs, such as amphotericin B, azoles, and echinocandins was evaluated by the broth microdilution method proposed by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Following the EUCAST-proposed breakpoints, 20% and 25% of the clinical and environmental isolates of A. fumigatus, respectively, were found to be resistant to itraconazole (Minimal Inhibitory Concentration, MIC > 2.0 mg/L). Voriconazole showed good activity against A. fumigatus and A. flavus strains, except for one clinical strain of A. fumigatus whose MIC was 4.0 mg/L. Posaconazole (≤0.25 mg/L) also showed appreciable activity against both species of Aspergillus, except for six A. fumigatus strains with relatively higher MICs (0.5 mg/L). The MICs for Amphotericin B ranged from 0.06 to 1.0 mg/L for A. fumigatus, but were much higher (0.5–8.0 mg/L) for A. flavus. Among the echinocandins, caspofungin showed a geometric mean of 0.078 and 0.113 against the clinical and environmental strains of A. flavus, respectively, but had elevated minimal effective concentrations (MECs) for seven of the A. fumigatus strains. Anidulafungin and micafungin exhibited considerable activity against both A. fumigatus and A. flavus isolates, except for one environmental isolate of A. fumigatus that showed an MEC of 1 mg/L to micafungin. Our study proposes that a detailed investigation of the antifungal susceptibility of the genus Aspergillus from different regions of Brazil is necessary for establishing a response profile against the different classes of antifungal agents used in the treatment of aspergillosis.

Saved in:
Bibliographic Details
Main Authors: Denardi,Laura Bedin, Hoch Dalla-Lana,Bianca, Pantella Kunz de Jesus,Francielli, Bittencourt Severo,Cecília, Santurio,Janio Morais, Zanette,Régis Adriel, Alves,Sydney Hartz
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000100030
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702018000100030
record_format ojs
spelling oai:scielo:S1413-867020180001000302018-05-29In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in BrazilDenardi,Laura BedinHoch Dalla-Lana,BiancaPantella Kunz de Jesus,FrancielliBittencourt Severo,CecíliaSanturio,Janio MoraisZanette,Régis AdrielAlves,Sydney Hartz Aspergillus flavus Aspergillus fumigatus Echinocandins Azoles Environmental Susceptibility ABSTRACT The in vitro susceptibility of 105 clinical and environmental strains of Aspergillus fumigatus and Aspergillus flavus to antifungal drugs, such as amphotericin B, azoles, and echinocandins was evaluated by the broth microdilution method proposed by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Following the EUCAST-proposed breakpoints, 20% and 25% of the clinical and environmental isolates of A. fumigatus, respectively, were found to be resistant to itraconazole (Minimal Inhibitory Concentration, MIC > 2.0 mg/L). Voriconazole showed good activity against A. fumigatus and A. flavus strains, except for one clinical strain of A. fumigatus whose MIC was 4.0 mg/L. Posaconazole (≤0.25 mg/L) also showed appreciable activity against both species of Aspergillus, except for six A. fumigatus strains with relatively higher MICs (0.5 mg/L). The MICs for Amphotericin B ranged from 0.06 to 1.0 mg/L for A. fumigatus, but were much higher (0.5–8.0 mg/L) for A. flavus. Among the echinocandins, caspofungin showed a geometric mean of 0.078 and 0.113 against the clinical and environmental strains of A. flavus, respectively, but had elevated minimal effective concentrations (MECs) for seven of the A. fumigatus strains. Anidulafungin and micafungin exhibited considerable activity against both A. fumigatus and A. flavus isolates, except for one environmental isolate of A. fumigatus that showed an MEC of 1 mg/L to micafungin. Our study proposes that a detailed investigation of the antifungal susceptibility of the genus Aspergillus from different regions of Brazil is necessary for establishing a response profile against the different classes of antifungal agents used in the treatment of aspergillosis.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.22 n.1 20182018-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000100030en10.1016/j.bjid.2017.10.005
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Denardi,Laura Bedin
Hoch Dalla-Lana,Bianca
Pantella Kunz de Jesus,Francielli
Bittencourt Severo,Cecília
Santurio,Janio Morais
Zanette,Régis Adriel
Alves,Sydney Hartz
spellingShingle Denardi,Laura Bedin
Hoch Dalla-Lana,Bianca
Pantella Kunz de Jesus,Francielli
Bittencourt Severo,Cecília
Santurio,Janio Morais
Zanette,Régis Adriel
Alves,Sydney Hartz
In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
author_facet Denardi,Laura Bedin
Hoch Dalla-Lana,Bianca
Pantella Kunz de Jesus,Francielli
Bittencourt Severo,Cecília
Santurio,Janio Morais
Zanette,Régis Adriel
Alves,Sydney Hartz
author_sort Denardi,Laura Bedin
title In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
title_short In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
title_full In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
title_fullStr In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
title_full_unstemmed In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil
title_sort in vitro antifungal susceptibility of clinical and environmental isolates of aspergillus fumigatus and aspergillus flavus in brazil
description ABSTRACT The in vitro susceptibility of 105 clinical and environmental strains of Aspergillus fumigatus and Aspergillus flavus to antifungal drugs, such as amphotericin B, azoles, and echinocandins was evaluated by the broth microdilution method proposed by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Following the EUCAST-proposed breakpoints, 20% and 25% of the clinical and environmental isolates of A. fumigatus, respectively, were found to be resistant to itraconazole (Minimal Inhibitory Concentration, MIC > 2.0 mg/L). Voriconazole showed good activity against A. fumigatus and A. flavus strains, except for one clinical strain of A. fumigatus whose MIC was 4.0 mg/L. Posaconazole (≤0.25 mg/L) also showed appreciable activity against both species of Aspergillus, except for six A. fumigatus strains with relatively higher MICs (0.5 mg/L). The MICs for Amphotericin B ranged from 0.06 to 1.0 mg/L for A. fumigatus, but were much higher (0.5–8.0 mg/L) for A. flavus. Among the echinocandins, caspofungin showed a geometric mean of 0.078 and 0.113 against the clinical and environmental strains of A. flavus, respectively, but had elevated minimal effective concentrations (MECs) for seven of the A. fumigatus strains. Anidulafungin and micafungin exhibited considerable activity against both A. fumigatus and A. flavus isolates, except for one environmental isolate of A. fumigatus that showed an MEC of 1 mg/L to micafungin. Our study proposes that a detailed investigation of the antifungal susceptibility of the genus Aspergillus from different regions of Brazil is necessary for establishing a response profile against the different classes of antifungal agents used in the treatment of aspergillosis.
publisher Brazilian Society of Infectious Diseases
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702018000100030
work_keys_str_mv AT denardilaurabedin invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
AT hochdallalanabianca invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
AT pantellakunzdejesusfrancielli invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
AT bittencourtseverocecilia invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
AT santuriojaniomorais invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
AT zanetteregisadriel invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
AT alvessydneyhartz invitroantifungalsusceptibilityofclinicalandenvironmentalisolatesofaspergillusfumigatusandaspergillusflavusinbrazil
_version_ 1756416551946289152